A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma
CPT: Pharmacometrics & Systems Pharmacology · 2025-03 · 14 (3) · 495-509
DOI: 10.1002/psp4.13290 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 30.12.2024. Verfasst von Daniel J Glazar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Mathematical Oncology, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Neoplasm Recurrence, Local, Models, Theoretical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Integrated Mathematical Oncology, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
- Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- The Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospital, Washington, DC, USA.
- Department of Radiation Oncology, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
- Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
- Department of Radiation Oncology, Loyola University, Chicago, Illinois, USA.
ORCID-Profile: Daniel J Glazar, Solmaz Sahebjam, Hsiang-Husan M Yu, Dung-Tsa Chen, Heiko Enderling
Förderung
- NCI NIH HHS
Zitieren
APA
Glazar, D. J., Sahebjam, S., Yu, H. M., Chen, D. T., Bhandari, M., & Enderling, H. (2025). A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma. CPT: Pharmacometrics & Systems Pharmacology, 14(3), 495-509. https://doi.org/10.1002/psp4.13290
Vancouver
Glazar DJ, Sahebjam S, Yu HM, Chen DT, Bhandari M, Enderling H. A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma. CPT: Pharmacometrics & Systems Pharmacology. 2025;14(3):495-509. doi:10.1002/psp4.13290
BibTeX
@article{Glazar2025,
author = {Glazar, Daniel J and Sahebjam, Solmaz and Yu, Hsiang-Husan M and Chen, Dung-Tsa and Bhandari, Menal and Enderling, Heiko},
title = {A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2025},
volume = {14},
number = {3},
pages = {495--509},
doi = {10.1002/psp4.13290}
}
EUVIMED